(Q35168207)

English

Lipid lowering drugs

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

1 reference

Europe PubMed Central

Lipid lowering drugs (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

author name string

O'Connor P

1

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Feely J

2

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Shepherd J

3

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

language of work or name

0 references

publication date

1 March 1990

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

300

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

6725

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

667-672

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Treatment of hypercholesterolemia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1662400

13 July 2018

Familial dysbetalipoproteinemia. New aspects of pathogenesis and diagnosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1662400

13 July 2018

How LDL receptors influence cholesterol and atherosclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1662400

13 July 2018

Total and high density lipoprotein cholesterol in the serum and risk of mortality: evidence of a threshold effect

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1662400

13 July 2018

Pathogenesis and management of lipoprotein disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1662400

13 July 2018

Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1662400

13 July 2018

Effects of fenofibrate on plasma lipids. Double-blind, multicenter study in patients with type IIA or IIB hyperlipidemia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1662400

13 July 2018

Effects of fenofibrate on plasma lipoproteins in hypercholesterolemia and combined hyperlipidemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1662400

13 July 2018

Comparative toxicity and safety profile of fenofibrate and other fibric acid derivatives

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1662400

13 July 2018

Pharmacology of fenofibrate

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1662400

13 July 2018

Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1662400

13 July 2018

Bezafibrate. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hyperlipidaemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1662400

13 July 2018

HMG-CoA reductase inhibitors for treatment of hypercholesterolemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1662400

13 July 2018

High density lipoprotein cholesterol is not a major risk factor for ischaemic heart disease in British men.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1662400

13 July 2018

Treatment of homozygous familial hypercholesterolaemia with probucol.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1662400

27 September 2018

The plasma lipoproteins as risk factors: comparison of electrophoretic and ultracentrifugation results.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1662400

27 September 2018

Effects of therapy with cholestyramine on progression of coronary arteriosclerosis: results of the NHLBI Type II Coronary Intervention Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1662400

27 September 2018

Comparative evaluation of the effects of ciprofibrate and fenofibrate on lipids, lipoproteins and apoproteins A and B

1 reference

https://pubmed.ncbi.nlm.nih.gov/2182155

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of probucol on xanthomata regression in familial hypercholesterolemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/2182155

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Drug treatment for hypercholesterolaemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/2182155

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of short-term treatment with bezafibrate on plasma fibrinogen, fibrinopeptide A, platelet activation and blood filterability in atherosclerotic hyperfibrinogenemic patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/2182155

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cholestyramine promotes receptor-mediated low-density-lipoprotein catabolism

1 reference

https://pubmed.ncbi.nlm.nih.gov/2182155

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Normalization of low-density-lipoprotein levels in heterozygous familial hypercholesterolemia with a combined drug regimen

1 reference

https://pubmed.ncbi.nlm.nih.gov/2182155

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lipoproteins, cardiovascular disease, and death. The Framingham study

1 reference

https://pubmed.ncbi.nlm.nih.gov/2182155

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dose-response study of the effect of ciprofibrate on serum lipoprotein concentrations in hyperlipoproteinaemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/2182155

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ciprofibrate in the therapy of type II hypercholesterolemia. A double-blind trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/2182155

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of hyperlipidaemia retards progression of symptomatic femoral atherosclerosis. A randomised controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/2182155

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influence of Gemfibrozil and Clofibrate on Metabolism of Cholesterol and Plasma Triglycerides in Man

1 reference

https://pubmed.ncbi.nlm.nih.gov/2182155

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

New developments in lipid-lowering therapy: the role of inhibitors of hydroxymethylglutaryl-coenzyme A reductase

1 reference

https://pubmed.ncbi.nlm.nih.gov/2182155

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasma lipid lowering activity of acipimox in patients with type II and type IV hyperlipoproteinemia. Results of a multicenter trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/2182155

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1136/BMJ.300.6725.667

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35168207&oldid=1954129090"